π R&D Intensity Calculator
What share of revenue goes back into research?
R&D intensity
Estimates for planning only, not financial advice.
R&D intensity is research and development spending divided by revenue. A company spending $2.5 million on R&D against $20 million of revenue runs at 12.5 percent intensity. The ratio shows how seriously a business bets on future products, and it is the standard way to compare innovation effort across companies of different sizes.
Absolute R&D dollars impress in headlines, but the ratio is what matters. A giant spending $1 billion at 2 percent intensity is coasting; a smaller rival spending $200 million at 18 percent is swinging. Investors, acquirers, and grant programs all read the ratio, not the raw number.
How to Use This Calculator
Enter annual R&D spending, annual revenue for the same period, and optionally the R&D headcount. Use figures from the same fiscal year, and use the accounting definition of R&D your books already use so the trend stays comparable.
Enter total R&D spending for the year: salaries, labs, prototypes, and contracted research.
Enter total revenue for the same year, so the ratio compares like with like.
Add R&D headcount if you want spend per researcher, a useful hiring benchmark.
Read the intensity percentage and the industry read. Track it yearly; the trend beats any single reading.
The R&D Intensity Formula
Spend per researcher = R&D spending / R&D headcount
The formula normalizes spending by company size. Two firms can spend wildly different dollars at the same intensity, which is precisely the comparison the ratio enables. Spend per researcher adds a second lens: it shows whether the budget funds deep work or just more meetings.
Accounting definitions vary. US GAAP expenses most R&D immediately, while some development costs can be capitalized under IFRS once technical feasibility is proven. Neither is wrong, but switching definitions mid-series breaks the trend, so document which one you use.
Worked Example
$2.5 million of R&D spending on $20 million of revenue gives $2,500,000 / $20,000,000 = 0.125, or 12.5 percent intensity. With 45 R&D employees, spend per researcher is $2,500,000 / 45 = $55,556. That per-head figure covers salary, benefits, equipment, and lab overhead blended together.
Benchmark it: software companies often run 10 to 20 percent, pharmaceuticals 15 to 25 percent, and industrial manufacturers 2 to 5 percent. At 12.5 percent, our example company looks like a serious software or electronics innovator, or an unusually aggressive industrial firm. The right benchmark is always the companyβs own industry, not the economy-wide average.
What Intensity Levels Mean by Industry
| Sector | Typical R&D intensity | Notes |
|---|---|---|
| Pharmaceuticals | 15% to 25% | Long cycles, patent cliffs, huge trial costs |
| Semiconductors | 12% to 20% | Process shrinks demand constant reinvestment |
| Software | 10% to 20% | Talent-heavy; cloud shifted some spend to opex |
| Automotive | 4% to 6% | EV transition is pushing this up |
| Industrials | 2% to 5% | Incremental innovation, long product lives |
| Retail / services | Under 2% | Innovation shows up elsewhere, not in R&D |
A ratio far above industry norms is either a moat being built or money being burned; the financial statements will not tell you which. Look at what the spending produced: patents filed, products launched, and revenue from products under five years old. Spending without output is just cost.
Intensity Is Input, Not Output
The ratio measures effort, not results. A company can run 20 percent intensity for a decade and ship nothing, while a rival at 6 percent ships category winners. Pair intensity with output metrics: new-product revenue share, patent yield per dollar, and finally return on invested capital, which reveals whether the research earns its keep. For the full innovation accounting picture, our retention ratio calculator shows how much earnings are kept to fund that research in the first place.
The US R&D Tax Credit
America subsidizes research through the Section 41 credit: generally 20 percent of qualified research spending above a base amount, or 14 percent under the simplified method. Startups without income tax liability can apply up to $500,000 of it against payroll tax. The definition of qualified research is broader than lab coats: developing new software, improving manufacturing processes, and engineering new products all count.
Two warnings. First, since 2022, Section 174 requires capitalizing and amortizing domestic R&D over five years instead of expensing it immediately, which raised many companiesβ tax bills and surprised founders. Second, documentation wins audits: track projects, hours, and technical uncertainties contemporaneously. The credit rewards real experimentation, and the IRS can tell the difference between research and routine engineering. A good CPA pays for themselves here many times over.
R&D Alliances and Shared Cost
Few companies fund breakthrough research alone anymore. Joint ventures, university partnerships, and government grants spread the cost and the risk: the reported R&D intensity reflects only the companyβs share, while the effective research effort is larger. Pharma co-development deals and semiconductor consortiums are the classic examples. When comparing intensity across companies, check how much research rides off-balance-sheet through partnerships.
Grants deserve special attention in the ratio. Government funding that flows through the income statement can inflate or deflate reported R&D depending on accounting treatment, making two identical labs look different. Footnotes usually disclose the treatment; analysts adjust. The economic question is always the same regardless of accounting: how much real research is this business conducting per dollar of revenue, and what is it producing. Follow the science, not the ratio alone.
R&D Intensity and the Innovation Premium
Markets pay a premium for credible R&D pipelines long before products launch: biotech firms with no revenue trade on trial data, and tech giantsβ valuations embed years of future products. The intensity ratio is the input side of that premium. Investors compare R&D spend per pipeline candidate, per patent, per researcher, trying to price the productivity of the research itself. High intensity with a thin pipeline is the warning sign.
For private companies, intensity signals to acquirers and investors alike. A startup spending 40 percent of revenue on R&D is making an explicit bet that technology, not salesmanship, wins the market. That bet needs to be legible: roadmaps, technical milestones, and patent filings translate the ratio into a story. Numbers open the conversation; evidence closes it. Intensity without narrative is just burning cash loudly.
Estimates for planning only, not financial advice.
Frequently Asked Questions
What is R&D intensity?
R&D intensity is research and development spending divided by revenue, expressed as a percentage. It measures how much of each revenue dollar a company reinvests in research.
What is a good R&D intensity?
It depends on the industry. Software and pharma commonly run 10 to 25 percent, while industrials run 2 to 5 percent. Compare against direct competitors, not the whole economy.
How do you calculate R&D spending per employee?
Divide total R&D spending by R&D headcount. It blends salaries, benefits, equipment, and overhead into one hiring and budgeting benchmark.
Is higher R&D intensity always better?
No. It measures input, not output. High spending that produces no shippable products is waste. Check patents, launches, and new-product revenue alongside the ratio.
Does R&D spending include software development?
Under US GAAP, most software R&D is expensed as incurred, with limited capitalization after technological feasibility. Tax definitions, like the R&D credit, have their own broader rules.
What is the difference between R&D intensity and R&D yield?
Intensity is spending over revenue, an input measure. Yield is output per R&D dollar, such as new-product revenue per dollar spent. Track both.
Why do pharma companies have such high R&D intensity?
Drug development takes a decade and most candidates fail, so the winners must fund many losers. Patent protection then lets the successes pay back the portfolio.
Can small businesses use this metric?
Yes. Even a 10-person firm can track development spending over revenue. The ratio keeps the conversation about commitment level rather than raw dollars.
Does acquiring a company change R&D intensity?
Immediately, yes, since both numerator and denominator change. Acquired in-process R&D is treated separately in accounting, so restate the trend carefully after deals.
How does R&D intensity relate to growth?
Sustained high intensity in industries where research pays off tends to precede revenue growth by years. But the lag is long and uncertain, which is why investors discount it.